Commercial Services and Supplies
Company Overview of National Multiple Sclerosis Society
National Multiple Sclerosis Society is a not-for-profit organization that provides advocacy, fund raising, clinical services, client programs, and up-to-date information to individuals with multiple sclerosis, their families, and healthcare providers. The organization was founded in 1946 and is based in New York City with an additional office in Denver, Colorado.
733 Third Avenue
New York, NY 10017
Founded in 1946
Key Executives for National Multiple Sclerosis Society
President and Chief Executive Officer
President of Greater Delaware Valley Chapter
Compensation as of Fiscal Year 2014.
National Multiple Sclerosis Society Key Developments
Alzheimers Drug Discovery Foundation, Beyond Batten Disease Foundation and National Multiple Sclerosis Society Collaborate to Fund Repository of Promising CNS-Active Compounds
Feb 28 13
Alzheimers Drug Discovery Foundation, Beyond Batten Disease Foundation and National Multiple Sclerosis Society announced a funding collaboration to support the creation of the Collaborative CNS Screening Initiative (CCSI), a central repository of chemical compounds that have shown significant Central Nervous System (CNS) activity. Led by the Harvard NeuroDiscovery Center's Laboratory for Drug Discovery in Neurodegeneration (LDDN), at Brigham and Women's Hospital, the CCSI will share emerging compounds with the potential to treat diseases of the CNS among academic CNS drug discovery centers to maximize their potential and accelerate drug discovery efforts within the neuroscience community. Through the CCSI, screening and early-stage drug discovery centers will submit anonymous CNS-active compounds to a highly selective, shared library. Eligible compounds must have not only demonstrated potential through primary screens but be validated through secondary assays, and exhibit other promising characteristics such as benefiting from chemical optimization. The CCSI library will be made available to participating centers to include in their ongoing screening, which will increase the exposure of the shared compounds to a wide range of assays, diseases and conditions to identify beneficial activities. Centers that discover novel activity will be connected with the contributing center to discuss further drug development of the compound.
National Multiple Sclerosis Society Appoints Paul J. Rowland as Chairman of the Board of Trustees
Jan 30 13
Paul J. Rowland has been named chairman of the board of trustees for the Long Island chapter of National Multiple Sclerosis Society. The West Sayville resident is senior vice president for strategic planning at Sound Shore Health Systems in New Rochelle.
National Multiple Sclerosis Society Announces Executive Changes
Jan 16 13
Marianne Jackson became Chair of the Board of Trustees of the Greater Delaware Valley Chapter of the National Multiple Sclerosis Society at the chapter's Annual Meeting on December 4, 2012. She succeeds Brian R. DiDonato who served a three-year term. Jackson, a resident of Phoenixville, Pa. Before that, she worked at Merck in the human health division as a sales representative and quickly moved into strategic marketing roles. The chapter is also announced the appointment of two new members to its Board of Trustees. Gina Clark, senior vice president and chief marketing officer, AmerisourceBergen Corporation. Clark leads strategic marketing and integrated branding initiatives across the company and its business units.
Pari Hashemi, financial advisor, Wells Fargo Advisors, LLC.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|